News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,107 Results
Type
Article (40298)
Company Profile (289)
Press Release (670519)
Multimedia
Podcasts (53)
Webinars (13)
Section
Business (206735)
Career Advice (2022)
Deals (35767)
Drug Delivery (95)
Drug Development (82207)
Employer Resources (174)
FDA (16272)
Job Trends (15014)
News (349407)
Policy (32797)
Tag
Academia (2564)
Accelerated approval (5)
Adcomms (22)
Allergies (92)
Alliances (50214)
ALS (103)
Alzheimer's disease (1417)
Antibody-drug conjugate (ADC) (150)
Approvals (16271)
Artificial intelligence (287)
Autoimmune disease (25)
Automation (18)
Bankruptcy (361)
Best Places to Work (11738)
BIOSECURE Act (19)
Biosimilars (111)
Biotechnology (205)
Bladder cancer (89)
Brain cancer (31)
Breast cancer (351)
Cancer (2696)
Cardiovascular disease (204)
Career advice (1688)
Career pathing (30)
CAR-T (176)
CDC (25)
Cell therapy (478)
Cervical cancer (21)
Clinical research (67465)
Collaboration (957)
Company closure (3)
Compensation (634)
Complete response letters (19)
COVID-19 (2625)
CRISPR (53)
C-suite (293)
Cystic fibrosis (110)
Data (2794)
Decentralized trials (2)
Denatured (19)
Depression (53)
Diabetes (300)
Diagnostics (6416)
Digital health (21)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (129)
Drug pricing (116)
Drug shortages (27)
Duchenne muscular dystrophy (114)
Earnings (88351)
Editorial (41)
Employer branding (22)
Employer resources (149)
Events (115690)
Executive appointments (828)
FDA (17791)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (856)
Gene editing (123)
Generative AI (20)
Gene therapy (354)
GLP-1 (757)
Government (4483)
Grass and pollen (5)
Guidances (179)
Healthcare (18883)
Huntington's disease (28)
IgA nephropathy (34)
Immunology and inflammation (134)
Immuno-oncology (6)
Indications (36)
Infectious disease (2778)
Inflammatory bowel disease (146)
Inflation Reduction Act (9)
Influenza (56)
Intellectual property (110)
Interviews (316)
IPO (16760)
IRA (42)
Job creations (3683)
Job search strategy (1431)
Kidney cancer (13)
Labor market (49)
Layoffs (488)
Leadership (17)
Legal (7946)
Liver cancer (77)
Lung cancer (380)
Lymphoma (194)
Machine learning (9)
Management (58)
Manufacturing (355)
MASH (85)
Medical device (13432)
Medtech (13437)
Mergers & acquisitions (19677)
Metabolic disorders (770)
Multiple sclerosis (96)
NASH (16)
Neurodegenerative disease (108)
Neuropsychiatric disorders (30)
Neuroscience (2057)
NextGen: Class of 2025 (6542)
Non-profit (4500)
Now hiring (45)
Obesity (400)
Opinion (213)
Ovarian cancer (93)
Pain (101)
Pancreatic cancer (107)
Parkinson's disease (177)
Partnered (22)
Patents (277)
Patient recruitment (137)
Peanut (48)
People (58270)
Pharmaceutical (74)
Pharmacy benefit managers (20)
Phase I (21059)
Phase II (29763)
Phase III (22039)
Pipeline (1543)
Policy (175)
Postmarket research (2569)
Preclinical (8966)
Press Release (64)
Prostate cancer (130)
Psychedelics (31)
Radiopharmaceuticals (260)
Rare diseases (432)
Real estate (6002)
Recruiting (66)
Regulatory (22656)
Reports (50)
Research institute (2336)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (8)
RSV (45)
Schizophrenia (81)
Series A (144)
Series B (97)
Service/supplier (11)
Sickle cell disease (57)
Special edition (18)
Spinal muscular atrophy (147)
Sponsored (31)
Startups (3629)
State (2)
Stomach cancer (13)
Supply chain (71)
Tariffs (55)
The Weekly (32)
Vaccines (746)
Venture capitalists (48)
Weight loss (246)
Women's health (41)
Worklife (16)
Date
Today (143)
Last 7 days (506)
Last 30 days (2437)
Last 365 days (32019)
2025 (15120)
2024 (35567)
2023 (40489)
2022 (51639)
2021 (56245)
2020 (54472)
2019 (46904)
2018 (35314)
2017 (32520)
2016 (31953)
2015 (38033)
2014 (31864)
2013 (26784)
2012 (28960)
2011 (29624)
2010 (27684)
Location
Africa (729)
Alabama (63)
Alaska (7)
Arizona (243)
Arkansas (14)
Asia (39051)
Australia (6329)
California (7125)
Canada (2252)
China (644)
Colorado (305)
Connecticut (309)
Delaware (181)
Europe (84879)
Florida (1080)
Georgia (237)
Idaho (58)
Illinois (609)
India (26)
Indiana (347)
Iowa (16)
Japan (211)
Kansas (108)
Kentucky (27)
Louisiana (13)
Maine (64)
Maryland (996)
Massachusetts (5327)
Michigan (238)
Minnesota (432)
Mississippi (3)
Missouri (85)
Montana (28)
Nebraska (25)
Nevada (77)
New Hampshire (65)
New Jersey (1989)
New Mexico (29)
New York (2006)
North Carolina (1096)
North Dakota (8)
Northern California (3139)
Ohio (227)
Oklahoma (15)
Oregon (35)
Pennsylvania (1544)
Puerto Rico (17)
Rhode Island (36)
South America (1110)
South Carolina (32)
South Dakota (1)
Southern California (2657)
Tennessee (118)
Texas (1058)
United States (26551)
Utah (210)
Virginia (175)
Washington D.C. (72)
Washington State (611)
West Virginia (4)
Wisconsin (63)
711,107 Results for "ipsen biopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy
May 21, 2025
·
5 min read
Press Releases
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation
May 6, 2025
·
6 min read
Press Releases
Ipsen S.A. - Annual General Meeting held on 21 May 2025
May 22, 2025
·
6 min read
Press Releases
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
May 1, 2025
·
6 min read
Press Releases
Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance
April 16, 2025
·
7 min read
Press Releases
Ipsen announces issuance of €500 million inaugural Rated Public Bond
March 19, 2025
·
8 min read
Press Releases
GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025
April 29, 2025
·
8 min read
Press Releases
Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
March 12, 2025
·
6 min read
Press Releases
Navidea Biopharmaceuticals, Inc. Announces Extension of Authority to Implement a Reverse Stock Split
May 22, 2025
·
4 min read
Business
Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer
PARIS, FRANCE, 06 June 2024 - Ipsen, a global specialty-driven biopharmaceutical company, announced the appointment of Josep Catllà as EVP, Chief Corporate Affairs Officer, effective August 19, 2024.
June 6, 2024
·
6 min read
1 of 71,111
Next
